Literature DB >> 11303024

Functional characterization of phosphorylation of 69-kDa human choline acetyltransferase at serine 440 by protein kinase C.

T Dobransky1, W L Davis, R J Rylett.   

Abstract

Choline acetyltransferase, the enzyme that synthesizes the transmitter acetylcholine in cholinergic neurons, is a substrate for protein kinase C. In the present study, we used mass spectrometry to identify serine 440 in recombinant human 69-kDa choline acetyltransferase as a protein kinase C phosphorylation site, and site-directed mutagenesis to determine that phosphorylation of this residue is involved in regulation of the enzyme's catalytic activity and binding to subcellular membranes. Incubation of HEK293 cells stably expressing wild-type 69-kDa choline acetyltransferase with the protein kinase C activator phorbol 12-myristate 13-acetate showed time- and dose-related increases in specific activity of the enzyme; in control and phorbol ester-treated cells, the enzyme was distributed predominantly in cytoplasm (about 88%) with the remainder (about 12%) bound to cellular membranes. Mutation of serine 440 to alanine resulted in localization of the enzyme entirely in cytoplasm, and this was unchanged by phorbol ester treatment. Furthermore, activation of mutant enzyme in phorbol ester-treated HEK293 cells was about 50% that observed for wild-type enzyme. Incubation of immunoaffinity purified wild-type and mutant choline acetyltransferase with protein kinase C under phosphorylating conditions led to incorporation of [(32)P]phosphate, with radiolabeling of mutant enzyme being about one-half that of wild-type, indicating that another residue is phosphorylated by protein kinase C. Acetylcholine synthesis in HEK293 cells expressing wild-type choline acetyltransferase, but not mutant enzyme, was increased by about 17% by phorbol ester treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11303024     DOI: 10.1074/jbc.M011702200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders.

Authors:  Yiying Cai; Ciarán N Cronin; Andrew G Engel; Kinji Ohno; Louis B Hersh; David W Rodgers
Journal:  EMBO J       Date:  2004-05-06       Impact factor: 11.598

2.  Choline acetyltransferase: regulation and coupling with protein kinase and vesicular acetylcholine transporter on synaptic vesicles.

Authors:  Di Sha; Hong Jin; Richard D Kopke; Jang-Yen Wu
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 3.  Functional regulation of choline acetyltransferase by phosphorylation.

Authors:  Tomas Dobransky; R Jane Rylett
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

4.  Functional consequences and structural interpretation of mutations of human choline acetyltransferase.

Authors:  Xin-Ming Shen; Thomas O Crawford; Joan Brengman; Gyula Acsadi; Susan Iannaconne; Emin Karaca; Chaouky Khoury; Jean K Mah; Shimon Edvardson; Zeljko Bajzer; David Rodgers; Andrew G Engel
Journal:  Hum Mutat       Date:  2011-09-23       Impact factor: 4.878

5.  Chronic cerebral ischaemia forms new cholinergic mechanisms of learning and memory.

Authors:  E I Zakharova; Z I Storozheva; A M Dudchenko; A A Kubatiev
Journal:  Int J Alzheimers Dis       Date:  2010-12-20

6.  Analysis of Caenorhabditis elegans acetylcholine synthesis mutants reveals a temperature-sensitive requirement for cholinergic neuromuscular function.

Authors:  Janet S Duerr; John R McManus; John A Crowell; James B Rand
Journal:  Genetics       Date:  2021-08-09       Impact factor: 4.402

7.  Chaperone-Mediated Regulation of Choline Acetyltransferase Protein Stability and Activity by HSC/HSP70, HSP90, and p97/VCP.

Authors:  Trevor M Morey; Warren Winick-Ng; Claudia Seah; R Jane Rylett
Journal:  Front Mol Neurosci       Date:  2017-12-12       Impact factor: 5.639

Review 8.  Acetylcholine signaling system in progression of lung cancers.

Authors:  Jamie R Friedman; Stephen D Richbart; Justin C Merritt; Kathleen C Brown; Nicholas A Nolan; Austin T Akers; Jamie K Lau; Zachary R Robateau; Sarah L Miles; Piyali Dasgupta
Journal:  Pharmacol Ther       Date:  2018-10-03       Impact factor: 13.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.